LBIC: Apex at One Year: How Two Pioneering Tenants Shaped a Building and How the Building Shaped Them
26 May 2026
)
The Promise of a Building
When LBIC: Apex opened its doors one year ago, it represented more than a new physical space: it was an investment in the momentum, ambition, and translational capability of London’s life sciences community. Designed as a home for companies working at the frontiers of biology, LBIC: Apex was built to remove operational barriers, accelerate scientific iteration, and create a community where pioneering teams could thrive.
Being there from Day One
Two of the companies that defined LBIC: Apex’s first year - Baseimmune and Laverock Therapeutics -entered the building at pivotal moments in their evolution. Across their distinct journeys, both companies have come to exemplify what LBIC: Apex was created to support: ambitious science, resilient teams, and organisations evolving through moments of both opportunity and uncertainty. Their experiences over the past year reveal the many ways in which a well‑designed environment can shape the trajectory of dynamic biology-focused companies. Going beyond offering space and infrastructure to provide the stability, flexibility, and operational clarity that allow companies to focus on what matters most.
As we look back on LBIC: Apex’s first year, their stories embody the promise of the building: to be a place where pioneering ideas can grow, where teams can evolve with confidence, and where the foundations of tomorrow’s breakthroughs are being laid in real time.
For Baseimmune, LBIC: Apex was the backdrop to the resolution of where their technology could have the greatest patient impact. As new leadership arrived and the company pivoted decisively into fibrosis, the building offered a coherent home in which the team could reorganise, deepen its scientific focus, and prepare for the next round of milestone‑driven growth. Even as they focused their therapeutic direction and navigated the realities of a challenging fundraising landscape, the continuity of staying within the LBIC ecosystem enabled them to move forward with purpose and confidence. Their story illustrates how an environment that removes operational friction can give a company the right space it needs to think boldly, act decisively, and evolve quickly.
For Laverock, LBIC: Apex has been a catalyst for acceleration. The building’s design and LBIC’s operational support have enabled Laverock to scale their programmable gene control platform with greater efficiency, deepen collaborative ways of working, and continue building the momentum that will carry their organisation into future therapeutic domains. Their experience demonstrates how a well‑supported research environment amplifies the pace and quality of scientific discovery.
A Foundation for the Next Chapter
Together, their stories show that LBIC: Apex is not merely a physical space but a platform that serves companies at different stages, with different needs.
Their stories are distinct, but together they offer a compelling portrait of what it means to grow inside an environment that is both stabilising and catalytic. Both have emerged from their first year stronger, more focused, and more ambitious than when they arrived—setting the stage for a wider collection of journeys now unfolding across LBIC.
As LBIC: Apex enters its second year, these stories set the tone for what comes next. They signal the building’s growing identity as a place where companies can navigate complexity with confidence; where scientific ambition is matched by operational capability; and where the foundations of long-term impact are being quietly put in place every day. More stories from across the community will continue to emerge, each offering a new perspective on how this environment is shaping the next generation of innovation.
The year ahead will bring new discoveries, new challenges, and new chapters for every company, and LBIC will continue to evolve alongside them.
Learn more: